Brilacidin/Remdesivir Combination - COVID-19 100% viral load drop!

[anonymous]

Who's seen this, Amazing Brilacidin/Remdesivir Combination: In a test at the George Mason University RBL, the Lab combined Remdesivir with Brilacidin which resulted in a 99.85% Viral Load Reduction with insignificant traces of the virus remaining.

http://www.ipharminc.com/press-rele...ivir-reduces-viral-load-by-nearly-100-percent

 

[anonymous]

COVID-19 Drug Candidate Brilacidin Achieves a Selectivity Index Among the Highest Reported >300 in a human lung epithelial cell line. Exhibiting Potent Anti-SARS-CoV-2 Activity at Low Concentrations; Human Clinical Trial Forthcoming
Innovation Pharmaceuticals’ Brilacidin Inhibits Novel Coronavirus (COVID-19) by Almost 90% at the Lowest Concentration Tested to Date in a Human Lung Cell Line — Innovation Pharmaceuticals Inc.

 

[anonymous]

Who's seen this, Amazing Brilacidin/Remdesivir Combination: In a test at the George Mason University RBL, the Lab combined Remdesivir with Brilacidin which resulted in a 99.85% Viral Load Reduction with insignificant traces of the virus remaining.

http://www.ipharminc.com/press-rele...ivir-reduces-viral-load-by-nearly-100-percent

The data is In vitro. Lots of meds work in vitro. Lets see the viral load decrease in vivo.

 

[anonymous]

Brilacidin is one of the few drugs targeting COVID-19 that has been tested in human trials (a total of 8) for other clinical indications, providing an established safety and efficacy database on over 460 subjects, thereby potentially enabling it to rapidly help address the novel coronavirus crisis. Ongoing laboratory testing conducted at a U.S. Regional Biocontainment Laboratory (RBL), and at a Public Health Research Institute (PHRI), supports Brilacidin’s antiviral ability to safely inhibit SARS-CoV-2 in both human and animal cell lines.

 

[anonymous]

Vitro is coming, I'm strongly expecting the stock price to explode soon.

Innovation Pharmaceuticals has already announced a Pre-IND Meeting Request Granted by FDA for the Study of Brilacidin for the Treatment of COVID-19. Confirmation of the meeting being granted by FDA, with return of written responses, has been received in early October.

Innovation Pharmaceuticals Announces Pre-IND Meeting Request Granted by FDA for the Study of Brilacidin for the Treatment of COVID-19 — Innovation Pharmaceuticals Inc.